A highly efficient method to differentiate CGRP-expressing peptidergic nociceptors from human induced pluripotent stem cells
Stem Cell Reports · 2026
DOI: 10.1016/j.stemcr.2026.102971 ↗Kurz gefasst
Fachartikel in der Zeitschrift Stem Cell Reports, 2026. Verfasst von Galbha Duggal und 14 weiteren Autor:innen. Beteiligte Einrichtung: Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK; Oxford StemTech, The Oxford Science Park, Oxford, UK. Electronic add…. Hauptthemen laut MEDLINE: Nociceptors, Induced Pluripotent Stem Cells, Calcitonin Gene-Related Peptide, Cell Differentiation. Die Arbeit nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Innovative Medicines Initiative, NIHR Oxford Biomedical Research Centre, NIHR BRC.
Abstract (Originalsprache)
Pain disorders such as neuropathic pain and headache remain areas of considerable unmet need and considered high risk by pharma. Human-induced pluripotent stem cells (iPSC)-derived sensory neurons have already been used to accelerate translational research but the current differentiation protocols produce non-peptidergic nociceptors. We demonstrate for the first time the robust differentiation of hiPSC into peptidergic nociceptor lineage with high yield. These nociceptors express CGRP and TRPV1 and show functional maturity including the expression of TTX-resistant currents and responding to TRPV1 and TRPA1 agonists. Importantly, they were able to release CGRP basally and upon stimulation by inflammatory soup, which was inhibited upon the application of the 5-HT1B/1D/1F agonist, sumatriptan, a migraine prophylactic drug. We report the successful generation of a novel in vitro functional peptidergic nociceptor model which will allow investigation of disease mechanisms in pain and translational phenotypic drug screening for new effective pain therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK; Oxford StemTech, The Oxford Science Park, Oxford, UK. Electronic address: galbha.duggal@oxfordstemtech.com.
- Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.
- Global Portfolio & Project Management, Oncology R&D, Cambridge, UK.
- Department of Neurology, Faculty of Health and Medical Sciences, Danish Headache Center, Glostrup Hospital, University of Copenhagen, Glostrup, Denmark.
- UK Dementia Research Institute, Department of Psychological Medicine and Clinical Neuroscience, Cardiff University, Cardiff, UK.
- Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK.
Förderung
- Innovative Medicines Initiative
- NIHR Oxford Biomedical Research Centre
- NIHR BRC
- Seventh Framework Programme
Zitieren
APA
Duggal, G., Li, X., Pettingill, P., Lalic, T., Gupta, S. K., Høgsbro, C. F., Volpato, V., Webber, C., Bowden, R., Charou, D., Arunasalam, K., Maresca, M., Hicks, R., Chintawar, S., & Cader, M. Z. (2026). A highly efficient method to differentiate CGRP-expressing peptidergic nociceptors from human induced pluripotent stem cells. Stem Cell Reports. https://doi.org/10.1016/j.stemcr.2026.102971
Vancouver
Duggal G, Li X, Pettingill P, Lalic T, Gupta SK, Høgsbro CF, et al. A highly efficient method to differentiate CGRP-expressing peptidergic nociceptors from human induced pluripotent stem cells. Stem Cell Reports. 2026. doi:10.1016/j.stemcr.2026.102971
BibTeX
@article{Duggal2026,
author = {Duggal, Galbha and Li, Xinyu and Pettingill, Philippa and Lalic, Tatjana and Gupta, Shailesh Kumar and Høgsbro, Christine Flodgaard and Volpato, Viola and Webber, Caleb and Bowden, Rory and Charou, Despoina and Arunasalam, Kanisa and Maresca, Marcello and Hicks, Ryan and Chintawar, Satyan and Cader, M Zameel},
title = {A highly efficient method to differentiate CGRP-expressing peptidergic nociceptors from human induced pluripotent stem cells},
journal = {Stem Cell Reports},
year = {2026},
doi = {10.1016/j.stemcr.2026.102971}
}
EUVIMED